Nomination Committee nominates cell therapy expert to Idogen AB’s Board of Directors
Ahead of the Idogen AB (publ) Annual General Meeting on 12 May 2020, the Nomination Committee has presented its proposal regarding the election of and payment of fees to the Board of Directors and auditor. The Nomination Committee proposes the re-election of Agneta Edberg, Leif Salford and Christina Herder, and the election of Sharon Longhurst to succeed Karin Hoogendoorn, who has declined re-election. Agneta Edberg is proposed for re-election as Chairman of the Board.
The Nomination Committee ahead of the Annual General Meeting comprised Hans-Olov Sjögren, Leif G. Salford and Staffan